← Back to Search

BPA Tool for Stroke Prevention in Atrial Fibrillation (SUPPORT-AF IV Trial)

N/A

Waitlist Available

Led By Alok Kapoor, MD

Research Sponsored by University of Massachusetts, Worcester

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 12 months

Awards & highlights

SUPPORT-AF IV Trial Summary

This trial will test how well a shared clinical decision support tool can help 6 million Americans with atrial fibrillation get the right treatment to reduce their risk of stroke.

Who is the study for?

This trial is for adults with atrial fibrillation or flutter who've seen a primary care provider or heart specialist in the past year and have this condition noted in their health records. It's not for those under 18, pregnant women, prisoners, patients without an AF diagnosis, those with left atrial appendage closure, or hospice patients.Check my eligibility

What is being tested?

The study tests if a decision support tool within electronic health records can increase prescription of oral anticoagulants (AC) to prevent strokes in AF patients. Providers are split into two groups: one uses the tool (intervention group), while the other doesn't (control group).See study design

What are the potential side effects?

Since this trial involves using a decision support tool rather than medication, there are no direct side effects from interventions like drugs. However, increased AC use may lead to typical AC-related risks such as bleeding.

SUPPORT-AF IV Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 12 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~12 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Initiation of Oral Anticoagulation (AC) Use

Length of Duration for Oral Anticoagulation (AC) Use

Secondary outcome measures

Hospitalization for new Stroke, Transient Ischemic Attack, or Systemic Embolism Ischemic Attack /Systemic Embolism.

Incidence of Major Hemorrhage and Clinically Relevant non-major Bleeding

SUPPORT-AF IV Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: InterventionExperimental Treatment1 Intervention

Receive best practice advisory (BPA)

Group II: ControlActive Control1 Intervention

Does not receive best practice advisory (BPA)

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

University of Massachusetts, WorcesterLead Sponsor

342 Previous Clinical Trials

973,978 Total Patients Enrolled

7 Trials studying Atrial Fibrillation

36,309 Patients Enrolled for Atrial Fibrillation

University of FloridaOTHER

1,340 Previous Clinical Trials

713,073 Total Patients Enrolled

4 Trials studying Atrial Fibrillation

141 Patients Enrolled for Atrial Fibrillation

Alok Kapoor, MDPrincipal InvestigatorUMass Chan Medical School

4 Previous Clinical Trials

853 Total Patients Enrolled

3 Trials studying Atrial Fibrillation

691 Patients Enrolled for Atrial Fibrillation

Media Library

Atrial Fibrillation Research Study Groups: Intervention, Control

Atrial Fibrillation Clinical Trial 2023: Intervention Highlights & Side Effects. Trial Name: NCT05236556 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there vacancies for participants in this investigation?

"Clinicaltrials.gov reveals that this specific trial is no longer recruiting patients, as the last update was on May 5th 2023 and it was first posted December 15th 2022. Nevertheless, there are presently 497 other clinical trials actively seeking out candidates."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Supporting Use of AC Through Provider Profiling of Oral AC Therapy for AF IV

Alok Kapoor 2022. "Supporting Use of AC Through Provider Profiling of Oral AC Therapy for AF IV". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05236556.

All > Afib > Atrial Fibrillation